Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
144 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 65438 |
71 | 2 | HEPATITIS B VIRUS//HEPATITIS B//CHRONIC HEPATITIS B | 28379 |
183 | 1 | CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE | 4046 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CHRONIC HEPATITIS B | authKW | 2615261 | 20% | 42% | 805 |
2 | ENTECAVIR | authKW | 2140630 | 10% | 71% | 386 |
3 | LAMIVUDINE | authKW | 1941253 | 15% | 41% | 604 |
4 | ADEFOVIR | authKW | 885357 | 5% | 61% | 185 |
5 | TELBIVUDINE | authKW | 664410 | 3% | 74% | 115 |
6 | HEPATITIS B VIRUS | authKW | 642049 | 17% | 12% | 701 |
7 | ADEFOVIR DIPIVOXIL | authKW | 617591 | 3% | 63% | 125 |
8 | NUCLEOSTIDE ANALOGUES | authKW | 543148 | 2% | 75% | 93 |
9 | HBV DNA | authKW | 390397 | 4% | 32% | 155 |
10 | LAMIVUDINE RESISTANCE | authKW | 353926 | 1% | 81% | 56 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 131536 | 53% | 1% | 2149 |
2 | Virology | 28842 | 20% | 0% | 828 |
3 | Infectious Diseases | 9333 | 15% | 0% | 600 |
4 | Pharmacology & Pharmacy | 2029 | 15% | 0% | 616 |
5 | Microbiology | 940 | 8% | 0% | 313 |
6 | Medicine, General & Internal | 440 | 7% | 0% | 263 |
7 | Medical Laboratory Technology | 63 | 1% | 0% | 37 |
8 | Medicine, Research & Experimental | 53 | 3% | 0% | 107 |
9 | Immunology | 17 | 3% | 0% | 121 |
10 | Health Care Sciences & Services | 15 | 1% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HEPATOL | 92033 | 7% | 4% | 275 |
2 | NKC GASTROENTEROL HEPATOL | 84173 | 0% | 54% | 20 |
3 | LIVER UNIT | 80947 | 6% | 5% | 224 |
4 | U871 | 71156 | 1% | 29% | 32 |
5 | U271 | 68286 | 1% | 24% | 37 |
6 | SERV HEPATOL | 63595 | 2% | 8% | 97 |
7 | HEPATOL UNIT | 56414 | 2% | 10% | 72 |
8 | HEPATITIS | 48231 | 2% | 9% | 67 |
9 | MED HEPATOL | 43095 | 1% | 23% | 24 |
10 | TORONTO WESTERN GEN HOSP | 42441 | 0% | 42% | 13 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF VIRAL HEPATITIS | 124531 | 5% | 8% | 191 |
2 | ANTIVIRAL THERAPY | 98013 | 4% | 8% | 156 |
3 | HEPATOLOGY INTERNATIONAL | 65152 | 2% | 11% | 75 |
4 | JOURNAL OF HEPATOLOGY | 43122 | 5% | 3% | 207 |
5 | LIVER INTERNATIONAL | 40756 | 3% | 4% | 118 |
6 | HEPATOLOGY | 35413 | 6% | 2% | 235 |
7 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 21387 | 3% | 2% | 137 |
8 | HEPATITIS MONTHLY | 16373 | 1% | 5% | 42 |
9 | JOURNAL OF MEDICAL VIROLOGY | 15501 | 3% | 2% | 125 |
10 | HEPATOLOGY RESEARCH | 13165 | 2% | 2% | 69 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRONIC HEPATITIS B | 2615261 | 20% | 42% | 805 | Search CHRONIC+HEPATITIS+B | Search CHRONIC+HEPATITIS+B |
2 | ENTECAVIR | 2140630 | 10% | 71% | 386 | Search ENTECAVIR | Search ENTECAVIR |
3 | LAMIVUDINE | 1941253 | 15% | 41% | 604 | Search LAMIVUDINE | Search LAMIVUDINE |
4 | ADEFOVIR | 885357 | 5% | 61% | 185 | Search ADEFOVIR | Search ADEFOVIR |
5 | TELBIVUDINE | 664410 | 3% | 74% | 115 | Search TELBIVUDINE | Search TELBIVUDINE |
6 | HEPATITIS B VIRUS | 642049 | 17% | 12% | 701 | Search HEPATITIS+B+VIRUS | Search HEPATITIS+B+VIRUS |
7 | ADEFOVIR DIPIVOXIL | 617591 | 3% | 63% | 125 | Search ADEFOVIR+DIPIVOXIL | Search ADEFOVIR+DIPIVOXIL |
8 | NUCLEOSTIDE ANALOGUES | 543148 | 2% | 75% | 93 | Search NUCLEOSTIDE+ANALOGUES | Search NUCLEOSTIDE+ANALOGUES |
9 | HBV DNA | 390397 | 4% | 32% | 155 | Search HBV+DNA | Search HBV+DNA |
10 | LAMIVUDINE RESISTANCE | 353926 | 1% | 81% | 56 | Search LAMIVUDINE+RESISTANCE | Search LAMIVUDINE+RESISTANCE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |